All Relations between cud and cannabis

Publication Sentence Publish Date Extraction Date Species
Lydia Aletraris, Brian D Graves, Joyce J Ndung'. Assessing the Impact of Recreational Cannabis Legalization on Cannabis Use Disorder and Admissions to Treatment in the United States. Current addiction reports. vol 10. issue 2. 2023-06-02. PMID:37266190. while numerous studies have examined the impact of rcls on cannabis use, there is less research on the risk of developing cannabis use disorder (cud). 2023-06-02 2023-08-14 Not clear
Lydia Aletraris, Brian D Graves, Joyce J Ndung'. Assessing the Impact of Recreational Cannabis Legalization on Cannabis Use Disorder and Admissions to Treatment in the United States. Current addiction reports. vol 10. issue 2. 2023-06-02. PMID:37266190. this review summarizes the latest research on the effects of rcls on cud prevalence and cannabis treatment admissions. 2023-06-02 2023-08-14 Not clear
Qiana L Brown, Dvora Shmulewitz, Aaron L Sarvet, Kelly C Young-Wolff, Tyriesa Howard, Deborah S Hasi. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study. Drug and alcohol dependence. vol 248. 2023-06-02. PMID:37267745. cannabis use and cannabis use disorder (cud) are associated with mental health disorders, however the extent of this matter among pregnant and recently postpartum (e.g., new moms) women in the us is unknown. 2023-06-02 2023-08-14 Not clear
Qiana L Brown, Dvora Shmulewitz, Aaron L Sarvet, Kelly C Young-Wolff, Tyriesa Howard, Deborah S Hasi. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study. Drug and alcohol dependence. vol 248. 2023-06-02. PMID:37267745. associations between cannabis use, dsm-5 cud and dsm-5 mental health disorders (mood, anxiety, personality and post-traumatic stress disorders) were examined among a nationally representative sample of pregnant and postpartum women. 2023-06-02 2023-08-14 Not clear
Emese Kroon, Lauren Kuhns, Karis Colyer-Patel, Francesca Filbey, Janna Cousij. Working memory-related brain activity in cannabis use disorder: The role of cross-cultural differences in cannabis attitudes. Addiction biology. vol 28. issue 6. 2023-05-31. PMID:37252877. amount of cannabis use (grams/week), dsm-5 cud symptoms and cannabis use-related problems were assessed. 2023-05-31 2023-08-14 human
Sabrina Giguère, Stéphane Potvin, Mélissa Beaudoin, Laura Dellazizzo, Charles-Édouard Giguère, Alexandra Furtos, Karine Gilbert, Kingsada Phraxayavong, Alexandre Dumai. Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study. Journal of personalized medicine. vol 13. issue 5. 2023-05-27. PMID:37240936. cannabis use disorder (cud) is a complex issue, even more so when it is comorbid with a severe mental disorder (smd). 2023-05-27 2023-08-14 human
Lara N Coughlin, Erin E Bonar, Joshua Wieringa, Lan Zhang, Matthew J Rostker, Alyssa N Augustiniak, Grant J Goodman, Lewei Allison Li. Pilot trial of a telehealth-delivered behavioral economic intervention promoting cannabis-free activities among adults with cannabis use disorder. Journal of psychiatric research. vol 163. 2023-05-24. PMID:37224772. among those whose use develops into a cannabis use disorder (cud), <5% initiate and engage in treatment. 2023-05-24 2023-08-14 Not clear
Dvora Shmulewitz, Alan J Budney, Jacob T Borodovsky, Julia M Bujno, Claire A Walsh, Cara A Struble, Ofir Livne, Mohammad I Habib, Efrat Aharonovich, Deborah S Hasi. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of psychiatric research. vol 163. 2023-05-24. PMID:37224773. the dsm-5 criteria for cannabis use disorder (cud) combine dsm-iv dependence and abuse criteria (without legal problems) and new withdrawal and craving criteria. 2023-05-24 2023-08-14 Not clear
Dvora Shmulewitz, Alan J Budney, Jacob T Borodovsky, Julia M Bujno, Claire A Walsh, Cara A Struble, Ofir Livne, Mohammad I Habib, Efrat Aharonovich, Deborah S Hasi. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of psychiatric research. vol 163. 2023-05-24. PMID:37224773. this study examined the psychometric properties of the dsm-5 cud criteria among adults who used cannabis in the past 7 days (n = 5,119). 2023-05-24 2023-08-14 Not clear
Dvora Shmulewitz, Alan J Budney, Jacob T Borodovsky, Julia M Bujno, Claire A Walsh, Cara A Struble, Ofir Livne, Mohammad I Habib, Efrat Aharonovich, Deborah S Hasi. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of psychiatric research. vol 163. 2023-05-24. PMID:37224773. factor analysis was used to assess dimensionality, and item response theory analysis models were used to explore relationships between the criteria and the underlying latent trait (cud), and whether each criterion and the criteria set functioned differently by demographic and clinical characteristics: sex, age, state-level cannabis laws, reasons for cannabis use, and frequency of use. 2023-05-24 2023-08-14 Not clear
Dvora Shmulewitz, Alan J Budney, Jacob T Borodovsky, Julia M Bujno, Claire A Walsh, Cara A Struble, Ofir Livne, Mohammad I Habib, Efrat Aharonovich, Deborah S Hasi. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of psychiatric research. vol 163. 2023-05-24. PMID:37224773. in this online sample of adults with frequent cannabis use, evidence supports the reliability, validity, and utility of the dsm-5 cud diagnostic criteria set, which can be used for determining a major risk of cannabis use, i.e., cud, to inform cannabis policies and public health messaging, and for developing intervention strategies. 2023-05-24 2023-08-14 Not clear
E L Gräfe, H M O Reid, I Shkolnikov, K Conway, A Kit, C Acosta, B R Christi. Women are Taking the Hit: Examining the Unique Consequences of Cannabis Use Across the Female Lifespan. Frontiers in neuroendocrinology. 2023-05-22. PMID:37217080. this is increasingly important given the rise in cannabis potency, as well as the implications this has for the prevalence of cannabis use disorder (cud). 2023-05-22 2023-08-14 Not clear
E L Gräfe, H M O Reid, I Shkolnikov, K Conway, A Kit, C Acosta, B R Christi. Women are Taking the Hit: Examining the Unique Consequences of Cannabis Use Across the Female Lifespan. Frontiers in neuroendocrinology. 2023-05-22. PMID:37217080. therefore, this scoping review aims to discuss the prevalence of cannabis use and cud in women throughout their lifespan and provide a balanced prospective on the positive and negative consequences of cannabis use. 2023-05-22 2023-08-14 Not clear
Qian Liya Leng, Jamie O Lo, Shauna Rakshe, Andrea D Hildebrand, Olivia J Doyle, Kristen Mackiewicz Seghete, Alice Graha. The association between preconception cannabis use and depression and anxiety during pregnancy. General hospital psychiatry. vol 83. 2023-05-17. PMID:37196406. our study provides data on preconception cannabis use and cannabis use disorder (cud) during the pandemic and models the association between preconception cannabis use and depression and anxiety during pregnancy. 2023-05-17 2023-08-14 Not clear
Moriah R Harton, Zachary W Adams, Maria A Parke. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults. Experimental and clinical psychopharmacology. 2023-05-11. PMID:37166911. the goal of this study was to determine whether alcohol use disorder (aud), cannabis use disorder (cud), and/or nicotine dependence were associated with concurrent oud. 2023-05-11 2023-08-14 Not clear
Zachary L Mannes, Carol A Malte, Mark Olfson, Melanie M Wall, Katherine M Keyes, Silvia S Martins, Magdalena Cerdá, Jaimie L Gradus, Andrew J Saxon, Salomeh Keyhani, Charles Maynard, Ofir Livne, David S Fink, Sarah Gutkind, Deborah S Hasi. Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019. Pain. 2023-05-09. PMID:37159542. because cannabis use increases the risk of cannabis use disorders (cuds), we examined time trends in cud among vha patients with and without chronic pain, and whether these trends differed by age. 2023-05-09 2023-08-14 Not clear
Zachary L Mannes, Carol A Malte, Mark Olfson, Melanie M Wall, Katherine M Keyes, Silvia S Martins, Magdalena Cerdá, Jaimie L Gradus, Andrew J Saxon, Salomeh Keyhani, Charles Maynard, Ofir Livne, David S Fink, Sarah Gutkind, Deborah S Hasi. Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019. Pain. 2023-05-09. PMID:37159542. clinicians should monitor symptoms of cud among vha patients and others with chronic pain who use cannabis, and consider noncannabis therapies, particularly because the effectiveness of cannabis for chronic pain management remains inconclusive. 2023-05-09 2023-08-14 Not clear
Heng Xu, Sylvanus Toikumo, Richard C Crist, Klaudia Glogowska, Zeal Jinwala, Joseph D Deak, Amy C Justice, Joel Gelernter, Emma C Johnson, Henry R Kranzler, Rachel L Kembe. Identifying Genetic Loci and Phenomic Associations of Substance Use Traits: A Multi-trait Analysis of GWAS (MTAG) study. Addiction (Abingdon, England). 2023-05-08. PMID:37156939. genome-wide association studies (gwas) of opioid use disorder (oud) and cannabis use disorder (cud) have lagged behind those of alcohol use disorder (aud) and smoking, where many more loci have been identified. 2023-05-08 2023-08-14 Not clear
Carsten Hjorthøj, Wilson Compton, Marie Starzer, Dorte Nordholm, Emily Einstein, Annette Erlangsen, Merete Nordentoft, Nora D Volkow, Beth Ha. Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological medicine. 2023-05-04. PMID:37140715. previous research suggests an increase in schizophrenia population attributable risk fraction (parf) for cannabis use disorder (cud). 2023-05-04 2023-08-14 Not clear
Rachel L Tomko, Bethany J Wolf, Erin A McClure, Matthew J Carpenter, Kathryn M Magruder, Lindsay M Squeglia, Kevin M Gra. Who Responds to a Multi-Component Treatment for Cannabis Use Disorder? Using Multivariable and Machine Learning Models to Classify Treatment Responders and Non-Responders. Addiction (Abingdon, England). 2023-05-03. PMID:37132085. treatments for cannabis use disorder (cud) have limited efficacy and little is known about who responds to existing treatments. 2023-05-03 2023-08-14 Not clear